These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 409490)

  • 1. Prolactin binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors and liver in diabetic rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1977 Nov; 37(11):4070-4. PubMed ID: 409490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin binding to dissociated cells from rat mammary tumors and mammary gland.
    Smith RD; Hilf R; Senior AE
    Cancer Biochem Biophys; 1979; 3(3):117-21. PubMed ID: 121922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Gibson SL; Hilf R
    Cancer Res; 1980 Jul; 40(7):2343-8. PubMed ID: 6770998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin receptors in 7,12-dimethylbenz(a) anthracene-induced mammary tumors following endocrine ablation.
    Costlow ME; Buschow RA; McGuire WL
    Cancer Res; 1976 Nov; 36(11 Pt 1):3941-3. PubMed ID: 184919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors from rats subject to chronic caloric restriction.
    Ruggeri BA; Klurfeld DM; Kritchevsky D; Furlanetto RW
    Cancer Res; 1989 Aug; 49(15):4135-41. PubMed ID: 2501022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Shafie SM; Hilf R
    Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
    Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
    Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin receptors and androgen-induced regression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
    Costlow ME; Buschow RA; McGuire WL
    Cancer Res; 1976 Sep; 36(9 pt.1):3324-9. PubMed ID: 184948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Gibson SL; Hilf R
    Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between hormone binding and growth response of rat mammary tumor.
    Holdaway IM; Friesen HG
    Cancer Res; 1976 May; 36(5):1562-7. PubMed ID: 817797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
    Manni A; Trujillo JE; Pearson OH
    Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin binding in ovariectomy-responsive and ovariectomy-nonresponsive rat mammary carcinoma.
    Powell BL; Diamond EJ; Koprak S; Hollander VP
    Cancer Res; 1977 May; 37(5):1328-32. PubMed ID: 15719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
    Rose DP; Noonan JJ
    Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of casein-producing and -nonproducing cell populations from 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Johnson ML; Levy J; Rosen JM
    Cancer Res; 1983 May; 43(5):2199-209. PubMed ID: 6187446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
    Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
    Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors.
    Leung BS; Sasaki GH; Leung JS
    Cancer Res; 1975 Mar; 35(3):621-7. PubMed ID: 163687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.